首页> 美国卫生研究院文献>The Journal of Biophysical and Biochemical Cytology >Alterations in integrin receptor expression on chemically transformed human cells: specific enhancement of laminin and collagen receptor complexes
【2h】

Alterations in integrin receptor expression on chemically transformed human cells: specific enhancement of laminin and collagen receptor complexes

机译:化学转化的人类细胞上整合素受体表达的改变:层粘连蛋白和胶原受体复合物的特异性增强

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The abilities of malignant tumor cells to bind and migrate through basement membranes are important steps in invasion and metastasis. Malignant tumor cells would therefore be expected to express receptors on their surfaces for basement membrane and stromal components, such as collagens, laminin, and fibronectin, although the pattern of expression of these receptors on the malignant cells may be different from that on their normal progenitors. We report here that chemically transformed tumorigenic human cells express an altered pattern of integrin receptors on their cell surfaces as compared with their untransformed nontumorigenic counterparts. Specifically, N-methyl-N'-nitro-N- nitrosoguanidine transformation of HOS cells into highly tumorigenic cells results in a significant specific increase in the expression of (in descending order of level of cell surface expression) the integrins alpha 6/beta 1, alpha 2/beta 1, and alpha 1/beta 1, which are receptors for laminin, collagens, and collagen type IV and laminin, respectively. The level of expression of two fibronectin receptor integrins, alpha 5/beta 1 and alpha 3/beta 1, are, however, unaltered, whereas the level of expression of vitronectin receptor integrin, alpha v/beta 3, is drastically reduced on the transformed cells. Consistent with the increased expression of laminin and collagen receptors and the decreased expression of vitronectin receptors on the transformed cells, these cells attached three- to fivefold more strongly to laminin and collagen but attached very poorly to vitronectin. The MNNG-HOS cells were also found to have a greater potential for invasion through reconstituted basement membrane, matrigel, the major components of which are laminin and type IV collagen. The invasion of both the HOS and MNNG-HOS cells was inhibited 45-50% by a polyclonal anti- fibronectin receptor antibody. However, although the invasion of HOS cells could be inhibited up to 75% by an anti-alpha 6 monoclonal antibody, a similar concentration of this antibody had no effect on the alpha 6-overproducing MNNG-HOS cells. A fivefold higher concentration of this antibody did result in partial inhibition of MNNG-HOS invasion. These data indicate a critical role for the alpha 6/beta 1 laminin receptor in the invasion of these cells through basement membranes and demonstrate that chemical transformation of nontumorigenic human cells to highly tumorigenic cells is associated with an altered pattern of integrin expression which may play a direct role in the increased capacity of these cells to bind and invade through basement membranes.
机译:恶性肿瘤细胞结合并通过基底膜迁移的能力是侵袭和转移的重要步骤。因此,预期恶性肿瘤细胞在其表面表达基底膜和基质成分的受体,例如胶原蛋白,层粘连蛋白和纤连蛋白,尽管这些受体在恶性细胞上的表达方式可能与正常祖细胞上的表达方式不同。 。我们在这里报告说,化学转化的致癌人类细胞与未转化的非致瘤对应物相比,在其细胞表面表达了整合素受体改变的模式。具体而言,将HOS细胞的N-甲基-N'-硝基-N-亚硝基胍转化为高度致瘤细胞,导致整联蛋白alpha 6 / beta 1的表达显着特异性增加(按细胞表面表达水平的降序排列)。 ,α2 / beta 1和alpha 1 / beta 1分别是层粘连蛋白,胶原蛋白和IV型和层粘连蛋白胶原蛋白的受体。但是,两种纤连蛋白受体整联蛋白α5/β1和α3/β1的表达水平没有改变,而玻连蛋白受体整联蛋白αv/β3的表达水平在转化后急剧降低。细胞。与层粘连蛋白和胶原蛋白受体的表达增加以及转化细胞上玻连蛋白受体的表达降低相一致,这些细胞与层粘连蛋白和胶原蛋白的结合强度提高了三到五倍,而与玻连蛋白的结合却非常差。还发现MNNG-HOS细胞具有更大的通过重组基底膜基质胶侵袭的潜能,基质胶的主要成分是层粘连蛋白和IV型胶原。多克隆抗纤连蛋白受体抗体将HOS和MNNG-HOS细胞的侵袭抑制了45-50%。然而,尽管抗α6单克隆抗体可以抑制HOS细胞的侵袭高达75%,但是该抗体的相似浓度对过量生产α6的MNNG-HOS细胞没有影响。该抗体浓度的五倍高确实导致了对MNNG-HOS入侵的部分抑制。这些数据表明,α6/β1层粘连蛋白受体在这些细胞通过基底膜的侵袭中起着关键作用,并证明非致瘤性人类细胞向高度致瘤性细胞的化学转化与整联蛋白表达模式的改变有关,而整联蛋白的表达可能起着重要作用。这些细胞增加结合和侵袭基底膜的能力的直接作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号